Research News

Yongho Bae, PhD, assistant professor of pathology and anatomical sciences, has been awarded a five-year, $2.9 million grant from the National Heart, Lung and Blood Institute to continue his research into the effects of arterial stiffness on cardiovascular disease.

University at Buffalo faculty members Stelios Andreadis, PhD, and M. Laura Feltri, MD, have been elected fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals.

A new Jacobs School of Medicine and Biomedical Sciences study conducted at Oishei Children’s Hospital is one of the first to reveal that there were fewer cases of multi-system inflammatory syndrome in children (MIS-C) during the omicron wave of the pandemic than the delta wave.

From the time she heard about the inaugural Graduate Student Research Day, Taylor Wicks was thrilled with the opportunity to showcase her work.

Adults experiencing long COVID may be interested in a new University at Buffalo clinical trial that is testing low-dose lithium as a potential treatment.

Getting a paper published in the New England Journal of Medicine (NEJM) is a career-crowning achievement for any medical researcher. This fall, within one week, it happened to two members of the Department of Pediatrics in the Jacobs School of Medicine and Biomedical Sciences, both of whom also happen to be Jacobs School alumnae.

Yongho Bae, PhD, assistant professor of pathology and anatomical sciences, has received a $250,000 sponsored research award from the Empire Discovery Institute (EDI) to investigate the role a novel mechanotherapeutic target, discovered in his lab, may have on vascular and cardiac stiffening commonly associated with cardiovascular disease (CVD). 

As the holiday season kicks into high gear, Jacobs School of Medicine and Biomedical Sciences physicians and scientists have recommendations for how people can stay safe and healthy this holiday season amid some increasingly concerning signs.

Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of the Department of Neurology, is involved in trials of FcRn (neonatal FC receptor) antagonists that offers a new approach to treating myasthenia gravis (MG).